## USB: U.S. Bancorp - XLF: Financial Services

### Executive Summary

VALUE thesis: PEG 1.35 indicates fundamental undervaluation. Consistent execution (4/4 quarters beat estimates). Caution: declining volume (48% of avg), momentum weakening (-1.6% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($52.77)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. Fort Washington Investment Advisors Inc. OH Sells 26,022 Shares of U.S. Bancorp $USB**
- Source: MarketBeat | 20251230T121056 | Neutral | Relevance: 100%
- Fort Washington Investment Advisors Inc. OH has reduced its stake in U.S. Bancorp ($USB) by selling 26,022 shares, bringing its total ownership to 1,605,357 shares valued at $77.59 million. This sale represents a 1.6% decrease in their holdings, while senior insiders also made significant sales in October. U.S. Bancorp has declared a quarterly dividend of $0.52, offering a 3.8% yield, and analysts maintain a "Moderate Buy" rating with a consensus price target of $54.95.

**2. U.S. Bancorp Comments on Dodd-Frank Act Stress Test Results**
- Source: Industry Analysts, Inc. | 20251228T090845 | Bullish | Relevance: 100%
- U.S. Bancorp announced its preliminary stress capital buffer (SCB) is 2.6 percent, based on the 2025 Dodd-Frank Act Stress Test results, requiring a Common Equity Tier 1 (CET1) ratio at or above 7.1 percent. The company plans a 4 percent increase in its quarterly common stock dividend to $0.52 per share and will continue share repurchases. U.S. Bancorp's leadership affirmed the company is well-capitalized and prepared for economic downturns.

**3. U.S. Bancorp Options Spot-On: On December 30th, 313.4K Contracts Were Traded, With 252.44K Open Interest**
- Source: 富途牛牛 | 20251230T220923 | Neutral | Relevance: 100%
- On December 30th, U.S. Bancorp (USB.US) experienced significant options trading activity, with a total volume of 313.4K contracts, overwhelmingly dominated by call options (99.63%). The open interest for USB.US stood at 252.44K contracts, representing 100.95% of the 30-day average, indicating substantial ongoing positions. A notable transaction involved 13,270 call contracts at a $50.00 strike price expiring on January 16th, 2026, when the stock was trading at $54.30.

**4. U.S. Bancorp $USB Shares Purchased by Chemung Canal Trust Co.**
- Source: MarketBeat | 20251230T100635 | Somewhat-Bullish | Relevance: 100%
- Chemung Canal Trust Co. significantly increased its stake in U.S. Bancorp (NYSE:USB) by 205.5% in the third quarter, bringing its total holdings to $3.3 million. This increase is part of a broader trend of institutional investment in U.S. Bancorp, alongside insider selling by Chairman Andrew Cecere and EVP James L. Chosy. Analysts maintain a "Moderate Buy" rating for U.S. Bancorp, with an average target price of $54.95.

**5. US Bancorp stock: Quiet climb, louder questions as Wall Street edges back to ‘buy’**
- Source: AD HOC NEWS | 20251229T210843 | Somewhat-Bullish | Relevance: 100%
- US Bancorp's stock has been quietly climbing, shrugging off regional bank concerns and interest rate uncertainty, attracting renewed "buy" ratings from major banks. Investors are debating whether this represents an opportunity in a well-known regional lender or a potential value trap. The bank's performance is underpinned by steady gains, solid one-year returns, strong fee income, disciplined credit culture, and strategic focus on digital initiatives and customer relationships.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-18 | Truist Securiti | $58 | $52 | +12% |
| 2025-12-17 | Keefe, Bruyette | $58 | $53 | +9% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-18 | Truist Securiti | main | Hold |
| 2025-12-17 | Keefe, Bruyette | main | Market Perform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 3 ($1.34M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 40.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 2 |

**Top Holders:**
- Vanguard Group Inc: 9.3% (+0.9%)
- Blackrock Inc.: 8.3% (-1.8%)
- JPMORGAN CHASE & CO: 5.8% (+117.8%)
- FMR, LLC: 4.6% (+0.9%)
- State Street Corpora: 4.4% (+0.9%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-1.6% 5d) with bearish MACD, trend may be turning.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.35 suggests fair value with growth premium. Quality metrics strong (margin 28%). Analyst sentiment positive (2 raises, avg +10%). Insider selling cluster ($1.3M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $84.5B |
| Beta | 1.11 |
| 52W Range | $35.18 - $55.15 |
| Short Interest | 1.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.35 |
| Forward P/E | 11.1 |
| Current P/E | 12.0 |
| YoY Growth | 7.7% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 3.6% to 2.0% (-1.6% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 2.0pp (needs >4.0% for momentum thesis). MRS_5 (-0.1%) diverging from MRS_20 - short-term weakness emerging. Full SMA alignment bullish (above 20/50/200 SMAs). Volume at 48% of 20MA suggests lack of conviction. OFD pattern: -MLL (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 1.97% (CS: 79) | Neutral |
| RSI_14 | 69.4 | Neutral |
| MACD Histogram | -0.06 | Bearish |
| vs SMA20 | 1.021x | Above |
| vs SMA50 | 1.093x | Above |
| vs SMA200 | 1.181x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $54.31
- **Stop Loss:** $52.77 (2.8% risk)
- **Target:** $57.39 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 535
- **Position Value:** $29,055.85
- **Portfolio %:** 29.06%
- **Risk Dollars:** $825.00
- **Risk Per Trade:** 0.83%
- **Modifiers:** L1 110% | L2 75% | Combined 0.83x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.10x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with balanced risk signals and moderate market participation. VIX at 14.33 indicates calm conditions, while positive yield curve (+59bps) and stable economic data support continued expansion. Year-end positioning and Fed uncertainty create near-term caution, but no systemic risks evident.*

### Earnings

**Next:** 2026-01-20 (Est: $1.17)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.12 | $1.22 | +9.0% |
| 2025Q2 | $1.07 | $1.11 | +4.1% |
| 2025Q1 | $0.97 | $1.03 | +5.7% |
| 2024Q4 | $1.05 | $1.07 | +1.7% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*